Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:23 PM
Ignite Modification Date: 2025-12-24 @ 2:23 PM
NCT ID: NCT06839859
Eligibility Criteria: Inclusion Criteria (youth): 1. Identify as a sexual/gender minority (including youth questioning their sexual orientation and/or gender identity AND their identity must be known to their participating caregiver). 2. Identify as a person of color/belonging to a minority racial and/or ethnic group. 3. Be between the ages of 14 and 20 years 4. Read and speak English 5. Live in the United States 6. Report consistent access to a phone, tablet, and/or computer with high-speed internet access 7. Report an ability to attend eight, two-hour online sessions at pre-determined times 8. Report moderate to high levels of caregiver/family rejection 9. Not be at high-risk for suicide 10. Not be actively psychotic Inclusion Criteria (caregivers): 1. Be a caregiver (biological parent, stepparent, grandparent, aunt/uncle, or another adult who provides care) to an SGMY of color between the ages of 14 to 20 2. Be over the age of 18 3. Read and speak English 4. Live in the United States 5. Report consistent access to a phone, tablet, and/or computer with high-speed internet access. 6. Report an ability to attend nine, two-hour online sessions at pre-determined times. 7. Be aware of the SGM youth's minority identity 8. NOT identify as SGM 9. Report spending time with participating youth at least 5 waking hours per week 10. Not be at high-risk for suicide 11. Not be actively psychotic
Healthy Volunteers: True
Sex: ALL
Minimum Age: 14 Years
Study: NCT06839859
Study Brief:
Protocol Section: NCT06839859